Medication info

Amrovan Plus Tablet 5/160/5 mg

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.94mg / 1 tabletValsartan›160mg / 1 tabletRosuvastatin Calcium›5.2mg / 1 tablet
Manufacturer / importer
Samchundang Pharmaceutical Co., Ltd.
Appearance
Pale yellow-pink oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202106220 · Approved 2021.08.27

Summary

Main use
Treatment of hypertension, improvement of dyslipidemia, and suppression of atherosclerosis progression and cardiovascular risk
Who takes it
Adults
Adult dose
Take 1 tablet of this medicine once daily with water. It is recommended that it be taken at the same time each day, if possible (e.g., before breakfast). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and rosuvastatin. Patients taking an amlodipine/valsartan combination and rosuvastatin as separate products may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination Before administering the amlodipine/valsartan combination, it is recommended that the doses of the individual components (amlodipine or valsartan) be adjusted. However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to the amlodipine/valsartan combination may be considered as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). Do not administer the amlodipine/valsartan combination to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan must not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose. ▷ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and continue it throughout treatment. Rosuvastatin may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. Most patients are controlled with a maintenance dose of 10 milligrams once daily. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, up to a maximum of 20 milligrams daily. 2. Elderly patients: No dosage adjustment is required. 3. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering rosuvastatin 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or lower, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of rosuvastatin is contraindicated in some of these patients.

Ingredients

Manufacturer
Samchundang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension, improvement of dyslipidemia, and suppression of atherosclerosis progression and cardiovascular risk

  • Essential hypertension
  • primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • complex dyslipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • primary dysbetalipoproteinemia
  • risk factors for coronary heart disease
  • hypertension
  • low HDL cholesterol levels
  • smoking
  • family history of early coronary heart disease
View approved original text

This medication is used to control blood pressure in patients with essential hypertension using a combination of amlodipine and valsartan, and to improve hypercholesterolemia and dyslipidemia with the addition of rosuvastatin. Amlodipine and valsartan are effective for hypertensive patients whose blood pressure is not adequately controlled. Rosuvastatin helps to lower lipid levels in patients with hypercholesterolemia and familial hypercholesterolemia that are not managed by diet. Furthermore, rosuvastatin delays the progression of atherosclerosis, reduces the risk of cardiovascular diseases, and decreases the likelihood of stroke and myocardial infarction. This medication is used to improve cardiovascular health and to reduce overall cardiovascular risk by controlling both blood pressure and lipid levels.

How to take

Adult dose

Take 1 tablet of this medicine once daily with water. It is recommended that it be taken at the same time each day, if possible (e.g., before breakfast). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and rosuvastatin. Patients taking an amlodipine/valsartan combination and rosuvastatin as separate products may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination Before administering the amlodipine/valsartan combination, it is recommended that the doses of the individual components (amlodipine or valsartan) be adjusted. However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to the amlodipine/valsartan combination may be considered as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). Do not administer the amlodipine/valsartan combination to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan must not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose. ▷ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and continue it throughout treatment. Rosuvastatin may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. Most patients are controlled with a maintenance dose of 10 milligrams once daily. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, up to a maximum of 20 milligrams daily. 2. Elderly patients: No dosage adjustment is required. 3. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering rosuvastatin 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or lower, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of rosuvastatin is contraindicated in some of these patients.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnant. People with allergies to any ingredients in this medication or similar medications, as well as pregnant or nursing women, and patients with severe liver or kidney impairment should not use this medication. Patients with low sodium or fluid levels in the body should improve their condition before taking this medication, and if symptoms of low blood pressure occur during treatment, they should lie down immediately and seek medical attention if necessary. Patients with high potassium levels or who are taking medications that may increase potassium levels should frequently monitor their potassium levels and exercise caution. Patients with issues in kidney blood vessels or those who have received a kidney transplant, as well as those with a history of angioedema, require special observation when using this medication. Patients who have experienced heart failure or myocardial infarction should carefully monitor their condition, including kidney function, while on this medication. Acute myocardial infarction patients should be cautious as symptoms may worsen with this medication. Some ingredients in this medication can cause muscle-related side effects, such as myalgia or myopathy, and rarely rhabdomyolysis, so any abnormal muscle symptoms should be reported to healthcare providers immediately. Dizziness or fatigue may occur when driving or operating machinery, so caution is advised. This medication may affect liver and kidney functions, so regular liver and kidney function tests are recommended. There may be interactions with other medications, so if any other medications are being taken, it is essential to inform healthcare providers, especially when taken with specific antifungal agents, antibiotics, immunosuppressants, or fibrates. This medication should not be used during pregnancy or while nursing, and women planning to become pregnant should use appropriate contraception. Safety and efficacy have not been established in children under 18 years of age, so it is not recommended. Elderly patients may be more sensitive to the medication, so it is advised to start at a lower dose and monitor their condition during administration. Overdose can lead to severe hypotension or shock, so immediate hospital attention is required for appropriate treatment.

Side effects

  • Peripheral edema
  • heat sensation
  • increased ALT
  • increased AST
  • elevated blood creatinine
  • flank pain
  • neck pain
  • dizziness
  • sensory impairment
  • nasopharyngitis
Show 175 more
  • rash
  • pharyngitis
  • influenza
  • hypersensitivity
  • visual impairment
  • anxiety
  • headache
  • drowsiness
  • orthostatic dizziness
  • sensory abnormalities
  • vertigo
  • tinnitus
  • tachycardia
  • palpitations
  • syncope
  • orthostatic hypotension
  • hypotension
  • cough
  • throat and laryngeal pain
  • diarrhea
  • nausea
  • abdominal pain
  • constipation
  • thirst
  • erythema
  • hyperhidrosis
  • rash
  • itching
  • joint edema
  • low back pain
  • arthritis
  • muscle cramps
  • lethargy
  • pollakiuria
  • polyuria
  • erectile dysfunction
  • edema
  • localized edema
  • facial edema
  • fatigue
  • flushing
  • weakness
  • facial flushing
  • chest pain
  • pain
  • nocturia
  • chest discomfort
  • abdominal discomfort
  • gastroesophageal reflux disease
  • hypercholesterolemia
  • hypoglycemia
  • urticaria
  • thrombocytopenia
  • leukopenia
  • allergic reaction
  • hyperglycemia
  • insomnia
  • mood changes
  • tremors
  • taste abnormalities
  • peripheral neuropathy
  • hypertonicity
  • arrhythmia
  • bradycardia
  • atrial fibrillation
  • ventricular tachycardia
  • vasculitis
  • dyspnea
  • rhinitis
  • vomiting
  • dyspepsia
  • pancreatitis
  • gastritis
  • gingival hyperplasia
  • hepatitis
  • jaundice
  • alopecia
  • purpura
  • skin depigmentation
  • photosensitivity reaction
  • angioedema
  • urticaria
  • erythema multiforme
  • Stevens-Johnson syndrome
  • myalgia
  • dysuria
  • nocturia
  • serum sickness
  • elevated serum potassium
  • vasculitis
  • bullous dermatitis
  • myalgia
  • renal failure
  • kidney damage
  • insomnia
  • decreased libido
  • pharyngitis
  • rhinitis
  • sinusitis
  • upper respiratory infection
  • viral infection
  • intestinal vascular edema
  • interstitial lung disease
  • jaundice
  • hepatitis
  • elevated transaminases
  • lupus-like syndrome
  • muscle rupture
  • immune-mediated necrotizing myopathy
  • hematuria
  • depression
  • sleep disorders
  • interstitial lung disease
  • sexual dysfunction
  • gynecomastia
  • fatal and non-fatal liver failure
  • post-marketing reported memory decline
  • forgetfulness
  • amnesia
  • memory impairment
  • confusion
  • myasthenia gravis
  • ocular myasthenia
  • weight loss
  • weight gain
  • pain
  • malaise
  • chest pain
  • elevated blood creatinine
  • arthralgia
  • skeletal pain
  • rhabdomyolysis
  • gingival hyperplasia
  • gastritis
  • neuroexcitability
  • Stevens-Johnson syndrome
  • polyneuropathy
  • memory loss
  • peripheral neuropathy
  • cough
  • dyspnea
  • thrombocytopenia
  • skin neoplasm
  • skin infection
  • dermatitis
  • palpitations
  • angina exacerbation
  • auditory abnormalities
  • vestibulitis
  • overactive bladder
  • increased blood pressure
  • hypertension exacerbation
  • fracture
  • osteomyelitis
  • herpes zoster
  • herniated disc
  • laceration
  • acute renal failure
  • oliguria
  • thrombocytopenia
  • elevated blood creatinine
  • myopathy
  • myositis
  • rhabdomyolysis
  • weakness
  • constipation
  • nausea
  • abdominal pain
  • itching
  • abnormal liver function tests
  • syncope
  • generalized pain
  • muscle cramps
  • gout
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container as it may be sensitive to air or moisture. Additionally, it should be kept at room temperature between 1 to 30 degrees Celsius, avoiding extremely hot or cold environments.

Appearance and packaging

Appearance

Pale yellow-pink oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.